Neurocrine Biosciences (NBIX) EV to EBIT (2009 - 2026)
Neurocrine Biosciences (NBIX) EV to EBIT (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EV to EBIT |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 15.12 |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.56 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 15.05 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -17,823.51 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 19.08 |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 13.31 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 34.10 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 20.65 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -177.73 |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 118.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 8, 2026 | 19.08 |
| Jun 5, 2026 | 19.21 |
| Jun 4, 2026 | 19.65 |
| Jun 3, 2026 | 19.37 |
| Jun 2, 2026 | 18.02 |
| Jun 1, 2026 | 18.83 |
| May 29, 2026 | 18.50 |
| May 28, 2026 | 18.25 |
| May 27, 2026 | 18.18 |
| May 26, 2026 | 18.21 |
| May 22, 2026 | 18.29 |
| May 21, 2026 | 18.29 |
| May 20, 2026 | 18.04 |
| May 19, 2026 | 18.00 |
| May 18, 2026 | 18.37 |
| May 15, 2026 | 18.51 |
| May 14, 2026 | 18.67 |
| May 13, 2026 | 18.88 |
| May 12, 2026 | 18.18 |
| May 11, 2026 | 17.52 |